A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...

A large study shows that routine H&E pathology slides contain rich spatial proteomic signals that can be decoded by AI to ...

By comparing clinical cohorts and populations from Singapore and the US, researchers will study infectious diseases, corneal disorders, liver transplant outcomes, diabetes and lung cancer to uncover ...

The global Proteomics Market is on a rapid growth trajectory, projected to reach USD 134.82 billion by 2035 from an estimated USD 44.79 billion in 2025, reflecting a robust CAGR of 11.7%. Driven by ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

New diagnostic chip pulls packets released from tumor cells out of blood, showing whether cancer cells died during ...

Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.

Immunopeptidomics is an emerging and rapidly evolving field that focuses on the identification of peptides presented by major ...

Objectives Delays in cancer diagnosis for patients with non-specific symptoms (NSSs) lead to poorer outcomes. Rapid Diagnostic Clinics (RDCs) expedite care, but most NSS patients do not have cancer, ...